Cancer Immunology, Immunotherapy,volume 58,issue 2  (02-2014)

Period of time： 2014年2期

Publisher： Springer Publishing Company

Founded in： 1976

Total resources： 35

ISSN： 0340-7004

Subject： R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cancer Immunology, Immunotherapy,volume 58,issue 2

Menu

Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary

By Mizejewski Gerald in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 159-170 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

MHC-dependent desensitization of intrinsic anti-self reactivity

By Jubala Cristan in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 171-185 (15)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes

By Bettahi Ilham,Dasgupta Gargi,Renaudet Olivier,Chentoufi Aziz,Zhang Xiuli,Carpenter Dale,Yoon Susan,Dumy Pascal,BenMohamed Lbachir in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 187-200 (14)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route

By Ge Wei in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 201-208 (8)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)

By Durai Malarvizhi in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 209-220 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Identification of novel tumor antigens with patient-derived immune-selected antibodies

By Rodriguez-Pinto Daniel in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 221-234 (14)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis

By Diaz David in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 235-245 (11)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients

By Kobayashi Ryuji in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 247-258 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Topotecan enhances immune clearance of gliomas

By Wei Jun,DeAngulo Guillermo,Sun Wei,Hussain Sakina,Vasquez Hernan,Jordan Justin,Weinberg Jeffery,Wolff Johannes,Koshkina Nadya,Heimberger Amy in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 259-270 (12)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients

By Godet Yann in (2009)

Cancer Immunology, Immunotherapy,volume 58,issue 2 , Vol. 58, Iss. 2, 2009-02 , pp. 271-280 (10)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 15 item(s)